Adderall's stimulant properties influence neurotransmitters like dopamine and norepinephrine, aiding in impulse control and attention regulation. While beneficial for ADHD patients, misuse or unauthorized use for cognitive enhancement can lead to adverse effects such as anxiety, insomnia, and increased blood pressure. It is a Schedule II controlled substance due to its potential for abuse. Adderall should not be shared, and its use must be closely monitored to prevent dependency. It's crucial for individuals to be transparent with healthcare providers about their medical history and any concerns to ensure safe and effective treatment.